Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients.
Key facts
- Where
- Chengdu, ChinaSee the site
- Phase
- Phase 2
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT07339774, who can take part
Where in China
- West China HospitalChengdu, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- West China Hospital
- Trial code
- NCT07339774
- Record updated
- 6 November 2026
- Original description
Evaluate the effectiveness and safety of traditional Chinese medicine compound in improving radiotherapy-induced oral mucositis in patients with head and neck malignant tumors.Read full original descriptionShow less
Chinese Herbal Oral Solution and Mouthwash Shorten the Duration of Severe Radiotherapy-induced Oral Mucositis in Patients With Head and Neck Malignancies.
Evaluate the effectiveness and safety of traditional Chinese medicine compound in improving radiotherapy-induced oral mucositis in patients with head and neck malignant tumors.
Inclusion: Patients pathologically diagnosed with non-metastatic head and neck malignant tumors; Age range: 18 to 65 years old (including 18 and 65 years old); Eastern Cooperative Oncology Group performance status of ≤2; Radiotherapy or concurrent chemoradiotherapy is required; The main organ functions well; Sign informed consent.
Exclusion: Use of antibiotics, antifungal drugs, or antimicrobial mouthwash within 1 month of the study; Deemed unsuitable for the study by the investigators (concomitant with any other severe diseases); Allergic constitution (such as those known to be allergic to two or more drugs); Poor oral hygiene and/or severe periodontal diseases; History of head and neck radiotherapy; Patients who plan to use drugs that can cause or worsen oral mucosal inflammation (such as anti EGFR monoclonal antibodies, immune checkpoint inhibitors, etc.) after the start of radiotherapy.